Document is current
Any future updates will be listed below
-
Authors
Loboda, Anna
Paluncic, Jasmina
Freitas, Micaela
Weidmann, Marko
Herter, Sonja
Zeiser, Constantia
Schulz, Juliana P.
Jády, Attila
Blattner-Johnson, Mirjam
Autry, Robert J.
Frese, Karen
Lupar, Dmitry
Schneider, Martin
Imle, Roland
Banito, Ana
Glimm, Hanno
Witt, Olaf
Peterziel, Heike
Kelm, Jens M.
Ball, Claudia R.
Oehme, Ina
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (HEROES-AYA)
Bundesministerium für Bildung und Forschung (HEROES-AYA)
Bundesministerium für Bildung und Forschung (HEROES-AYA)
Bundesministerium für Bildung und Forschung (HEROES-AYA)
- License Information
-
More Information
Article History
Received: 30 October 2025
Accepted: 2 June 2026
First Online: 17 June 2026
Competing interests
: This study was supported and in direct collaboration with PreComb Therapeutics AG. Micaela Freitas and Jens M. Kelm are both employees of PreComb Therapeutics AG. Ina Oehme and Claudia R Ball received research funding from PreComb Therapeutics. Olaf Witt participated in the advisory boards of Novartis, BMS and Janssen and received research grants from BVD and Day One Therapeutics. I.O. received a research grant from Day One Therapeutics. The other authors declare no competing interests.
